NZ771630A - Methods of detecting prostate cancer - Google Patents

Methods of detecting prostate cancer

Info

Publication number
NZ771630A
NZ771630A NZ771630A NZ77163014A NZ771630A NZ 771630 A NZ771630 A NZ 771630A NZ 771630 A NZ771630 A NZ 771630A NZ 77163014 A NZ77163014 A NZ 77163014A NZ 771630 A NZ771630 A NZ 771630A
Authority
NZ
New Zealand
Prior art keywords
prostate cancer
subject
methods
neutro
macro
Prior art date
Application number
NZ771630A
Other versions
NZ771630B2 (en
Inventor
Harry Stylli
Colleen Kelly
Amin I Kassis
Geoffrey Erickson
Kirk J Wojno
Original Assignee
Immunis Ai Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunis Ai Inc filed Critical Immunis Ai Inc
Publication of NZ771630A publication Critical patent/NZ771630A/en
Publication of NZ771630B2 publication Critical patent/NZ771630B2/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Disclosed is a method for diagnosing or aiding in the diagnosis of prostate cancer in a subject, the method comprising the steps of: a) measuring the levels of one or more markers selected from the group consisting of PC-MACRO/PC-NEUTRO 1-200 in a population of the subject’s macrophage cells; b) measuring the levels of the one or more selected PC-MACRO/PC-NEUTRO markers in a population of the subject’s non-phagocytic cells; and c) identifying a difference between the measured levels of the one or more selected PC-MACRO/PC-NEUTRO markers in steps a) and b), wherein the identified difference indicates that the subject has the prostate cancer.
NZ771630A 2014-03-07 Methods of detecting prostate cancer NZ771630B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361775559P 2013-03-09 2013-03-09
NZ75386214 2014-03-07

Publications (2)

Publication Number Publication Date
NZ771630A true NZ771630A (en) 2023-01-27
NZ771630B2 NZ771630B2 (en) 2023-04-28

Family

ID=

Similar Documents

Publication Publication Date Title
MY188938A (en) Therapeutic, diagnostic and prognostic methods for cancer of the bladder
MX361058B (en) Methods for detecting 5t4-positive circulating tumor cells and methods of diagnosis of 5t4-positive cancer in a mammalian subject.
GB2515983A (en) Methods and compositions for providing a preeclampsia assessment
EP4060048A3 (en) Non-invasive diagnostic method for diagnosing bladder cancer
MX367046B (en) Pathway specific markers for diagnosing irritable bowel syndrome.
GB2545361A (en) Protein biomarker panels for detecting colorectal cancer and advanced adenoma
MX2013000917A (en) Methods of detecting diseases or conditions using phagocytic cells.
NZ629555A (en) Monocyte biomarkers for cancer detection
WO2014165487A3 (en) Cement evaluation
MX2016012697A (en) Protein biomarker profiles for detecting colorectal tumors.
MX2022002138A (en) Prostate antigen standards and uses thereof.
WO2014137820A3 (en) Systems and methods for associating microposts with geographic locations
EP2619587A4 (en) Biomarkers for recurrence prediction of colorectal cancer
MX364119B (en) Apparatus and methods of data analysis.
WO2013185779A3 (en) Biomarkers for prostate cancer
IL254119A0 (en) Whole blood based mrna markers for predicting prostate cancer and methods of detecting the same
MX2016001719A (en) Methods and kits for predicting the risk of having a cardiovascular disease or event.
MX2014013337A (en) Methods and systems for measurement and verification weighting with temperature distribution.
MA40636A (en) Methods of detecting prostate cancer
MX2016012278A (en) Early detection of preeclampsia.
MX2015013993A (en) Methods and arrays for use in biomarker detection for prostate cancer.
MX363679B (en) Method of diagnosing cancer.
IN2015DN01646A (en)
GB201204785D0 (en) Method for determining prognosis of prostate cancer in a subject
WO2014143794A3 (en) Diagnostic and prognostic marker for prostate cancer

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: IMMUNIS.AI, INC., US

Effective date: 20220823

ERR Error or correction

Free format text: THE INVENTOR HAS BEEN CORRECTED TO 3156533, STYLLI, HARRY, 2452 PASEO DORADO, LA JOLLA, CA 92037, CA, US; 3157210, KELLY, COLLEEN, 7302 GOLDEN STAR LANE, CARLSBAD, CA 92011, US; 3849995, KASSIS, AMIN I, 582 NW, VAN BUREN AVENUE, CORVALLIS, ORGEON, US; 3849997, ERICKSON, GEOFFREY, 582 NW, VAN BUREN AVENUE, CORVALLIS, ORGEON, US; 3849999, WOJNO, KIRK J., 582 NW, VAN BUREN AVENUE, CORVALLIS, OREGON, US

Effective date: 20220831

PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 6 YEARS UNTIL 07 MAR 2024 BY SPRUSON + FERGUSON PTY LTD

Effective date: 20230602

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 07 MAR 2025 BY COMPUTER PACKAGES INC

Effective date: 20240217